AI recognizes an increase in insulin demand and increase in body temperature.?? This leads to a lower risk of getting infected and reduces the severity of the disease.
All
Team
Company
Patients
Physicians
Hospital
Partners
Mission
Innovation Details
Supporters
Comments
Updates
About our project
The problem we solve: Diabetes makes patients more vulnerable to infection, both bacterial and viral. This is because an elevated blood glucose provides an environment for microorganisms to thrive and multiply. Not only that, but elevated blood glucose interrupts the ability of our white blood cells to fight infection.
About our solution:
Diabetics can better maintain their blood sugar levels. Patients can be informed when symptoms of an infection occur. This leads to a lower risk of getting infected and reduces the severity of the disease in the event of an infection.
diafyt determines the individual insulin demand of patients with type 1 diabetes using machine learning methods. An increase in insulin demand is an indicator of infection. In addition, data analysis detects an increase in body temperature. This allows us to identify the signs of coronavirus infection.
Progress to
date:
Diafyt is for type 1 diabetics, has TRL8, is a medical device, has CE mark for distribution in Europe, has been launched at Google Play store in DE, FR, ES, IT and UK. We would be able to build a COVID-19 enabled app in less than 3 month for US users and patients worldwide. However we are short of resources to build and ship as fast as needed.
About Our Team
Creator: Thomas Wuttke
Location: Sachsen
Education: MSEE, LAW
Bio: we are a team!
1# Engineer, diabetic, founder (me)
2# Mathematics PhD
3# Medical doctor, PhD, Professor and clinical researcher
4# Engineer, PhD, university researcher
5# Manager for financials, sales and marketing
Title: Founder
About Our Company
diafyt MedTech
Location: Schwägrichenstr.3 Leipzig, SN 04107 DE
Founded: 2016
Product
Stage: Ready
Employees: 3-5
How We Help Patients
the COVID-19 product will reduce the amount of infections
How We Help Physicians
the COVID-19 product will reduce the amount of infections
How We Help Hospitals
the COVID-19 product will reduce the amount of infections
How We Help Partners
the COVID-19 product will reduce the amount of infections
Challenge Mission
COVID Problem We Address
Fever is an indicator of COVID-19 infection. Regular fever measurement therefore helps to detect an infection early. A continuous measurement of the body temperature over 2 weeks can indicate a non-infection.
Our COVID Solution
The aim is to build a device that records body temperature over a longer period of time. A smartphone app can display the recorded data and make it available for further analysis.
Use Cases:
diabetics wearing a CGM can monitor their body temperature
any person wearing a CTM can monitor their body temperature
the past history of a diabetics/persons body temperature profile can be shared
1. develop AI on top of existing AI with COVID functionality
2. develop interfaces to all CGM glucose sensors, build hacks if needed and to speed up availability to patients
3. design and build IOS release
4. build COVID release for Android (add-on for existing app)
4. FDA fast track or use EU certification CE mark
5. clinical trial
6. rollout to patients in the US, EU, world
Thank You
this is going to be a hell of a ride and you can be part of it .. your help is highly appreciated
Help us find best new ideas to fund by telling us what you think. Your feedback goes
straight to the team behind this project in private, so tell them what you really think.
we are a team!
1# Engineer, diabetic, founder (me)
2# Mathematics PhD
3# Medical doctor, PhD, Professor and clinical researcher
4# Engineer, PhD, univ...
AI recognizes an increase in insulin demand and increase in body temperature.?? This leads to a lower risk of getting infected and reduces the severity of the disease.
Thank you for visiting!
This area is for community members only. Please signin or signup and join our global community of people who care about medical innovation.
